Abstract
Rationale
As exogenous cannabinoid agonists impair memory formation, could it be that antagonists have opposing effects and act as memory-enhancing drugs?
Objectives
Here, we studied the effects of the cannabinoid antagonist SR141716A (SR; Rimonabant) on spatial learning and memory formation and assessed the possible involvement of hippocampal CB1 receptor in these actions.
Materials and methods
In the water maze, spatial reference memory was probed using different training protocols followed by assessment of behavioral flexibility. The CB1 receptor antagonist SR (3 mg/kg) was intraperitoneally administered before or immediately after training in experiment 1, or via minipumps intrahippocampally (0.89 ng and 0.089 ng/day) either during or after spatial learning, or subcutaneously in experiment 2.
Results
In experiment 1, systemic SR impaired spatial learning when given intraperitoneally (ip) before training coincident with increasing swim speed and thigmotaxis. Pretraining before drug treatment eliminated these effects while post-training injections had no effect. In experiment 2, intrahippocampal infusion of 0.089 ng SR during training enhanced acquisition learning, but did not affect long-term consolidation of spatial memory. In contrast, subcutaneous infusion of SR via minipumps had no effect. Post-training infusion of SR did not affect reversal learning, but short-term memory (1 h post-training) was weaker, and long-term memory for the reversal platform location was enhanced.
Conclusions
Systemic Rimonabant-induced deficits are due to anxiogenic properties of the drug. The difference between administration regimes is discussed in terms of CB1 receptor blockade in multiple non-memory and memory-related brain regions and the possibility that selective inactivation of hippocampal CB1 receptors may be memory enhancing.
Similar content being viewed by others
References
Bass CE, Griffin G, Grier M, Mahadevan A, Razdan RK, Martin BR (2002) SR141716A induced stimulation of locomotor activity: a structure–activity relationship study. Pharmacol Biochem Behav 74:31–40
Beiko J, Candusso L, Cain DP (1997) The effect of nonspatial water maze pre-training in rats subjected to serotonin depletion and muscarinic receptor antagonism: a detailed behavioural assessment of spatial performance. Behav Brain Res 88(2):201–211
Braida D, Sala M (2000) Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats. Neuroreport 11(9):2025–2029
Bohme GA, Laville M, Ledent C, Parmentier M, Imperato A (2000) Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience 95(1):5–7
Brodkin J, Moerschbacher JM (1997) SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats. J Pharmacol Exp Ther 282:1526–1532
Ciccocioppo R, Antonelli L, Biondini M, Perfumi M, Pompei P, Massi M (2002) Memory impairment following combined exposure to Δ9-tetrahydrocannabinol and ethanol in rats. Eur J Pharmacol 449:245–252
Compton DR, Aceto MD, Lowe J, Martin BR (1996) In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of Delta (9)- tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277(2):586–594
Da Silva GE, Takahashi RN (2002) SR 141716A prevents Delta(9) tetrahydrocannabinol induced spatial learning deficit in a Morris-type water maze in mice. Prog Neuro-psychopharmacol Biol Psychiatry 26(2):321–325
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946–1949
Egashira N, Mishima K, Iwasaki K, Fujiwara M (2002) Intracerebral microinjections of Δ9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight- arm radial maze in rats. Brain Res 952:239–245
Hampson RE, Deadwyler SA (1999) Cannabinoids, hippocampal function and memory. Life Sciences 65(6/7):715–723
Hampson RE, Deadwyler SA (2000) Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J Neurosci 20(23):8932–8942
Hampson RE, Simeral JD, Kelly EJ, Deadwyler SA (2003a) Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons. Hippocampus 13(5):543–556
Hampson RE, Zhuang SY, Weiner JL, Deadwyler SA (2003b) Functional significance of cannabinoid-mediated, depolarization-induced suppression of inhibition (DSI) in the hippocampus. J Neurophysiol 90(1):55–64
Holter SM, Kallnik M, Wurst W, Marsicano G, Lutz B, Wotjak CT (2005) Cannabinoid CB1 receptor is dispensable for memory extinction in an appetitively-motivated learning task. Eur J Pharmacol 510(1–2):69–74
Kamprath K, Marsicano G, Tang JR, Monory K, Bisogno T, Di Marzo V, Lutz B, Wotjak CT (2006) Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J Neurosci 26(25):6677–6686
Lichtman AH (2000) SR141716A enhances spatial memory assessed in a radial-arm maze task in rats. Eur J Pharmacol 404:175–179
Lichtman AH, Martin BR (1996) Δ9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacol 126:125–131
Lichtman AH, Dimen KR, Martin BR (1995) Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacol 119:282–290
Maccarrone M, Valverde O, Barbaccia ML, Castane A, Maldonado R, Ledent C, Parmentier M, Finazzi-Argo A (2002) Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. Eur J Neurosci 15:1178–1186
Mansbach RS, Rovetti CC, Winston EN, Lowe JA (1996) Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacol 124:315–322
Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530–534
Mallet PE, Beninger RJ (1998) The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by Δ9-Tetrahydrocannabinol or anandamide. Psychopharmacol 140:11–19
Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O (2002) Involvement of CB1 cannabinoid receptors in emotional behavior. Psychopharmacol 159:379–387
Martin SJ, deHoz L, Morris RG (2005) Retrograde amnesia: neither partial nor complete hippocampal lesions in rats result in preferential sparing of remote spatial memory, even after reminding. Neuropsychologia 43:609–624
Mechoulam R, Benshabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50(1):83–90
Micheau J, Riedel G, Roloff EL, Inglis J, Morris RG (2004) Reversible hippocampal inactivation partially dissociates how and where to search in the watermaze. Behavioral Neuroscience 118:1022–1032
Mishima K, Egashira N, Hirosawa N, Fujii M, Matsumoto Y, Iwasaki K, Fujiwara M (2001) Characteristics of learning and memory impairment induced by Δ9-tetrahydrocannabinol in rats. Jpn J Pharmacol 87:297–308
Morris RGM, Moser EI, Riedel G, Martin SJ, Sandin J, Day M, O’Carroll C (2003) Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. Phil Trans R Soc Lond B Biol Series 358:773–786
Nava F, Carta G, Colombo G, Gessa GL (2001) Effects of chronic Δ9-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze. Neuropharmacology 41:392–399
Navarro M, Hernandez E, Munoz RM, delArco I, Villanua MA, Carrera MRA, deFonseca FR (1997) Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport 8(2):491–496
Pamplona FA, Prediger RDS, Pandolfo P, Takahashi RN (2006) The cannabinoid receptor agonist WIN 55,212–2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology 188(4):641–649
Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic, San Diego, CA
Pertwee RG (2005) Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sciences 76:1307–1324
Reibaud M, Obinu MC, Ledent C, Parmentier M, Bohme GA, Imperato A (1999) Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur J Pharmacol 379:R1–R2
Riedel G, Micheau J (2001) Function of the hippocampus in memory formation: desperately seeking resolution. Progr NeuroPsychopharmacol Biol Psychiatry 25:835–853
Riedel G, Micheau J, Lam AG, Roloff EL, Martin SJ, de Hoz L, Poeschel B, McCulloch J, Morris RG (1999) Reversible neural inactivation reveals hippocampal participation in several memory processes. Nature Neurosci 2:898–905
Rinaldi-Carmona M, Barth F, Heaulme M, Alonso R, Shire D, Congy C, Soubrie P, Breliere JC, Lefur G (1995) Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci 56(23–24):1941–1947
Robinson L, Riedel G (2004) Cannabinoid function in spatial learning: an update. Current Neuropharmacology 2(1):125–143
Robinson L, Hinder L, Pertwee RG, Riedel G (2003) Effects of Δ9-THC and WIN-55,212-2 on place preference in the water maze in rats. Psychopharmacology 166:40–50
Robinson L, Platt B, Riedel G (2004) Cannabinoids. Memories are made of these. Landes Biosciences, New York, NY, USA, pp 314–329
Saucier D, Hargreaves EL, Boon F, Vanderwolf CH, Cain DP (1996) Detailed behavioral analysis of water maze acquisition under systemic NMDA or muscarinic antagonism: nonspatial pretraining eliminates spatial learning deficits Behav Neurosci 110(1):103–116
Takahashi RN, Pamplona FA, Fernandes MS (2005) The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze. Neurosci Lett 380:270–275
Terranova JP, Storme JJ, Lafon N, Perio A, Rinaldi-Carmona M, Le Fur G, Soubrie P (1996) Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology 126:165–172
Varvel SA, Lichtman AH (2002) Evaluation of CB1 receptor knockout mice in the Morris water maze. J Pharmacol Exp Ther 301(3):915–924
Varvel SA, Hamm RJ, Martin BR, Lichtman AH (2001) Differential effects of Δ9-THC on spatial reference and working memory in mice. Psychopharmacology 157:142–150
Varvel SA, Anum EA, Lichtman AH (2005) Disruption of CB1 receptor signaling impairs extinction of spatial memory in mice. Psychopharmacology 179:863–872
White NM, McDonald RJ (2002) Multiple parallel memory systems in the brain of the rat. Neurobiol Learn Mem 77(2):125–184
Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410(6828):588–592
Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296(5568):678–682
Wolff MC, Leander JD (2003) SR141716A, a cannabinoid CB1 receptor antagonist improves memory in a delayed radial maze task. Eur J Pharmacol 477:213–217
Acknowledgement
This work was supported by a component grant from the MRC to GR and RGP, and NIH grant DA08549 to REH. There is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robinson, L., McKillop-Smith, S., Ross, N.L. et al. Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats. Psychopharmacology 198, 551–563 (2008). https://doi.org/10.1007/s00213-007-1012-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-007-1012-8